JENBURPH

Jenburkt Pharmaceuticals LimitedNSE
₹1,039.9-3.10 (-0.30%)

Market Closed · NSE · INR

Open

₹1,052

High

₹1,052

Low

₹1,025.1

Prev Close

₹1,043

52-Week Range22% from low
₹938.05
₹1,392.65

Market Cap

₹0

P/E (TTM)

-

EPS

-

Div Yield

1.98%

P/B Ratio

-

ROE

-

Key Metrics

Forward P/E-
Book Value-
Debt/Equity-
Revenue Growth-
Profit Margin-
Operating Margin-
Volume276
Avg Volume (20d)2.0 K
Delivery %96.38%
Trades34

What If I Had Invested?

Chart data not available for this range

AI Analysis

Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.

AI Technical Analysis

Buy/sell zones with live web research

Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.

Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.

About

HealthcareDrug Manufacturers - Specialty & Generic

Jenburkt Pharmaceuticals Limited manufactures and markets pharmaceutical formulations in India and internationally. The company offers therapeutic solutions, such as analgesic and antipyretics, anthelmintics, anti-arthritic, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants ...

jenburkt.com801 employees

Technical Indicators

Loading sector benchmark…

Quality scores

Valuation bands

Intrinsic value calculators

Peer Comparison

Dividend History

Recent: 20.70/share
28 Aug 202620.70
Loading events…

Recent Filings (NSE)

Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.

Institutional Deals(NSE)

Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.

Governance Scorecard

AlphaView composite

Fund Actions

Loading fund activity…

News

News sourced from RSS feeds. Headlines link to original articles.

Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.